Jupiter Research Capital (Asia) Ltd’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Jupiter Research Capital (Asia) Ltd's CORT Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in Corcept Therapeutics (CORT) in Q3 2026: 72,402 shares worth $8.34M. The stake represents 0.92% of the portfolio and ranks #21 among its holdings. This is a return to the name: Jupiter Research Capital (Asia) Ltd previously reported a position in CORT as recently as Q1 2026.
Jupiter Research Capital (Asia) Ltd first reported a position in CORT in Q1 2026 and has held it in 2 quarters since. 463 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 72,402 shares of Corcept Therapeutics worth $8.34M as of Q3 2026.
- Corcept Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- Corcept Therapeutics made up 0.92% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #21 holding.
- Jupiter Research Capital (Asia) Ltd first reported a position in Corcept Therapeutics in Q1 2026 and has held it in 2 quarters since.
- 463 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.